MediciNova Inc. (NASDAQ:MNOV) Director Yutaka Kobayashi bought 11,800 shares of the business’s stock in a transaction that occurred on Thursday, September 15th. The shares were acquired at an average cost of $6.44 per share, for a total transaction of $75,992.00. Following the completion of the purchase, the director now owns 81,800 shares in the company, valued at $526,792. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Yutaka Kobayashi also recently made the following trade(s):

  • On Friday, September 9th, Yutaka Kobayashi acquired 10,000 shares of MediciNova stock. The stock was purchased at an average cost of $6.67 per share, for a total transaction of $66,700.00.

Shares of MediciNova Inc. (NASDAQ:MNOV) opened at 6.70 on Wednesday. MediciNova Inc. has a 12 month low of $2.62 and a 12 month high of $10.16. The firm has a 50 day moving average of $6.53 and a 200-day moving average of $6.86. The stock’s market capitalization is $230.96 million.

About MediciNova

MediciNova, Inc is a biopharmaceutical company. The Company is focused on acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States market. It is focused on its development activities on MN-166 (ibudilast) for neurological disorders and MN-001 (tipelukast) for fibrotic diseases, such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF).

5 Day Chart for NASDAQ:MNOV

Receive News & Ratings for MediciNova Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediciNova Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.